Illumina

The U.S. government has sounded the alarm about a critical software vulnerability found in genomics giant Illumina’s DNA sequencing devices, which hackers can exploit to modify or steal patients

In a recent interview discussing Bill Gates’ recent book “How to Avoid a Climate Disaster“, the Microsoft and Breakthrough Energy founder (and the world’s third wealthiest man)

Biotech has become one of the hottest areas of venture investment in recent years, as progress in machine learning, genetics, medical devices and biology fuse together into new products for the gargan

Since its launch in 1998, Illumina and its genetic analysis toolkits and services have become an essential component of the new biological manufacturing and therapeutic development industries that hav

Excitement in the consumer genetic testing market continues to show signs of slowing down. In the past two weeks, layoffs have hit two of the biggest consumer genetic testing services — 23andme and

In 1998, the startup company Illumina launched a revolution in the life sciences industry by developing technology to slash the costs of identifying and mapping genetic material. Now, a little over 20

A little over a year after the dissolution of the once high-flying blood testing startup Theranos, another startup has raised more than $27 million to breathe new life into the vision of bringing low-

The agriculture industry faces huge problems of sustainability. The world’s population is increasing, leading to higher food demand, but this then threatens increasing deforestation, pesticide u

New advances in genetic mapping and manipulation hold the promise of reshaping medical treatments in the 21st century, but thanks to a lack of sufficient infrastructure and apparent scientific disrega

This morning, a publicly traded transplant diagnostics company called CareDx, along with Stanford University, sued another publicly traded genetic testing company, Natera, for patent infringement. Muc

As healthcare moves toward genetically tailored treatments, one of the biggest hurdles to truly personalized medicine is the lack of fast, low-cost genetic testing. And few people are more familiar wi

Vitamins are proving to be a lucrative industry in the United States. Just last year vitamin sales pulled in roughly $37 billion for the U.S. economy. That’s up from $28 billion in 2010. To cas

Illumina Accelerator, the genomics-focused startup accelerator backed by the publicly traded genetic sequencing pioneer Illumina Corp., has picked five startups for its seventh accelerator class, the

Welcome to the future… where startups are willing to customize everything from a diet regimen to a workout plan, or family planning to personal fashion based on an individual’s genetic c

Life sciences startups need a whole lot more cash than most and that’s certainly true for GRAIL, a cancer detection startup trying to figure out a way to find the “emperor of all maladies&

The first sequencing of the whole human genome in 2003 cost roughly $2.7 billion, but DNA sequencing giant Illumina has now unveiled a new machine that the company says is “expected one day&#822

In recent years, a crop of companies have emerged that are using genomic sequencing to detect diseases in order to prevent the negative outcome of those diseases. It’s led to a budding ecosyste

Illumina is one of the leading companies when it comes to DNA sequencing. And today, the company is <a target="_blank" href="http://www.businesswire.com/news/home/20160728005475/en/">announcing</a> th

A San Francisco startup called Trace Genomics wants to help farmers diagnose and improve the health of the soil where they want to raise crops before it’s harvest time and too late to change course.